StepStone Group just raised $690 million for its latest growth equity fund focused on technology and healthcare.
StepStone Tactical Growth Fund III interestingly mixes fund, secondary and co-investments in order to build ‘diversified’ exposure to high-growth global technology and healthcare assets. The opportunistic nature of the strategy is eyeing venture capital and growth-equity backed companies as the team manages volatility, reduces fees and seeks to accelerate time to liquidity through innovative portfolio construction.
The fund is managed by StepStone partners Brian Borton, Andrew Callahan and John Coelho, following the Continue Reading Unlock this article instantly, along with the rest of our premium content and benefits including daily/weekly/monthly newsletters.
